CONTACT US   |  (864) 397-5101

Fountain Inn manufacturer invests; Greenville financial company sold for $360M

A manufacturer of advanced electronic components headquartered in Fountain Inn, Kyocera AVX, has invested in an early stage venture capital firm to complement its research and development programs and support innovation in the medical technology industry.

Good Growth Capital (GGC), a majority women-owned venture capital firm based in Charleston with offices in Boston, Mass., typically invests in complex science and deep-tech startups. The partnership was established in August and announced in a news release on Nov. 29.

“This investment provides Kyocera AVX with abundant opportunities to further support the flourishing tech industry both here in the Carolinas and nationwide by investing through GGC and exploring co-investments,” company CEO Johnny Sarvis said in the release.

Kyocera AVX has more than 30 research, design, manufacturing and customer support facilities in 16 countries. It invests in research and development and submits several patent applications annually, according to its website.

The company manufactures products for the automotive, industrial, medical, military, consumer electronics, communications and transportation markets. For the medical industry, the company creates products for devices such as pacemakers, cochlear implants and diagnostics equipment.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.